Eli Lilly wins ok for dog separation anxiety drug

BOSTON, April 25 (Reuters) - Drugmaker Eli Lilly and Co. (LLY.N) said on Wednesday that it won U.S. regulatory approval for its drug to treat separation anxiety in dogs.

The drug, Reconcile, is one of a class of drugs known as selective serotonin reuptake inhibitors, or SSRIs, which are also used to treat human depression.

((Reporting by Toni Clarke, editing by Gerald E. McCormick; Reuters Messaging, toni.clarke.reuters.com@reuters.net, 617-367-4165)) Keywords: LILLY/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWEN6989